Skylands Capital’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HEC
FLAM
PCM
Skylands Capital's ATRC Position: Q1 2018 in Review
Skylands Capital sold out of AtriCure (ATRC) in Q1 2018, closing a stake of 75,000 shares — an estimated $1.37M sold.
Skylands Capital first reported a position in ATRC in Q2 2013 and held it in 17 quarters. The position peaked at $2.58M in Q3 2014. 108 funds tracked by Wall St. Rank hold ATRC as of Q1 2018.
- Skylands Capital reported no remaining AtriCure position as of Q1 2018 after selling out during the quarter.
- Skylands Capital sold 75,000 AtriCure shares in Q1 2018, an estimated $1.37M.
- Skylands Capital first reported a position in AtriCure in Q2 2013 and held it in 17 quarters.
- Skylands Capital's AtriCure position peaked at $2.58M in Q3 2014.
- 108 funds tracked by Wall St. Rank held AtriCure as of Q1 2018.
Based on Skylands Capital's 13F filing for Q1 2018, filed 19 Apr 2018.